Morepen Laboratories - Quarterly Results
11th Nov 2021

The company witnessed a 17.42% growth in the revenue at Rs. 3693.88 millions for the quarter ended September 2021 as compared to Rs. 3145.99 millions during the year-ago period.The company has announced a 34.39% increase in its profits to Rs . 344.30  millions for the  quarter ended September 2021 compared to Rs. 256.19 millions in the corresponding quarter in the previous year.The company reported a good operating profit of 396.84 millions compared to 330.64 millions of corresponding previous quarter.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3693.88 3145.99 17.42 7346.19 5578.57 31.69 11124.23 7919.87 40.46
Other Income 28.54 37.33 -23.55 44.37 50.62 -12.35 117.74 94.17 25.03
PBIDT 396.84 330.64 20.02 839.10 596.66 40.63 1241.46 738.83 68.03
Interest -91.20 2.90 -3244.83 -89.09 5.77 -1644.02 17.88 19.68 -9.15
PBDT 488.04 327.74 48.91 928.19 590.89 57.08 1223.58 719.15 70.14
Depreciation 57.00 71.55 -20.34 110.96 146.25 -24.13 281.10 344.34 -18.37
PBT 431.04 256.19 68.25 817.23 444.64 83.80 942.48 374.81 151.46
TAX 86.74 0.00 0.00 164.46 0.00 0.00 0.00 51.49 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 344.30 256.19 34.39 652.77 444.64 46.81 942.48 323.32 191.50
Equity 899.59 899.59 0.00 899.59 899.59 0.00 899.59 899.59 0.00
PBIDTM(%) 10.74 10.51 2.22 11.42 10.70 6.79 11.16 9.33 19.63